Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro

Japanese Journal of Pharmacology

Volumn 71, Issue 4, 1996, Pages 291-298

  Goto, Shinichiro ^a   Egashira, Toru ^a   Wada, Yuji ^a   Takayama, Fusako ^a   Yamanaka, Yasumitsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

5 Hydroxytryptamine uptake; Fluvoxamine; Monkey brain; Monkey platelet; Paroxetine binding

Indexed keywords

DESIPRAMINE; FLUVOXAMINE; KETANSERIN; MAPROTILINE; NOMIFENSINE; NORADRENALIN; PAROXETINE; SEROTONIN 2 RECEPTOR; ZIMELDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; DOPAMINE UPTAKE; DRUG BINDING SITE; DRUG POTENCY; MALE; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; SEROTONIN UPTAKE; SEROTONINERGIC NERVE CELL; THROMBOCYTE;

EID: 0029843960     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.71.291     Document Type: Article

References (42)

1. Deakin JFW: Depression and 5-HT. Int Clin Psychopharmacol 6, Supp 3, 23-28 (1991)
2. Asberg M, Thoren P, Traskman L, Bertilsson L and Ringberger V: Serotonin depression, a biochemical subgroup within the affective disorder? Science 191, 478-480 (1976)
3. Korpi ER, Kleinman JE and Goodman SI: Serotonin and 5-hydroxyindoleacetic acid in brains of suicide victims: comparison in chronic schizophrenic patients with suicide as cause of death. Arch Gen Psychiatry 43, 594-600 (1986)
4. Guimaraes FS: New drugs, fluoxetine and fluvoxamine. Br J Hosp Med 45, 146-149 (1991)
5. Classen V: Review of the animal pharmacology and pharmacokinetics of fluvoxamine. Br J Pharmacol 15, 349s-355s (1983)
6. Benfield P and Ward A: Fluvoxamine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32, 313-334 (1986)
7. Wilde MI, Plosker GL and Benfield P: Fluvoxamine: An updated review of its pharmacology, and therapeutic use in depressive illness. Drugs 46, 895-924 (1993)
8. 3H-paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 486, 261-268 (1989)
9. Leysen JE: Serotonin receptor binding sites. In Neuropharmacology of Serotonin, Edited by Gree AR, pp 106- 108, Oxford University Press, London (1985)
10. 3H-paroxetine binding to rat cortical membranes. Eur J Pharmacol 118, 107-114 (1985)
11. 3H-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther 165, 78-86 (1969)
12. Egashira T, Yamamoto T and Yamanaka Y: Characteristics of mitochondrial and synaptosomal monoamine oxidase in monkey brain. Jpn J Pharmacol 34, 211-219 (1984)
13. McKeith IG, Marshall EF, Ferrier IN, Armstrong MM, Kennedy WN, Perry RH, Perry EK and Eccleston D: 5-HT receptor binding in post-mortem brain from patients with affective disorder. J Affect Disord 13, 67-74 (1987)
14. 3H-imipramine to human platelet membranes. Eur J Pharmacol 96, 303-309 (1983)
15. 2 receptor binding on platelets as a state dependent maker in major affective disorder. Psychopharmacology (Berlin) 102, 73-75 (1990)
16. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275 (1951)
17. 3H-5-hydroxytryptamine in slices of human and rat cortical brain tissue. Brain Res 275, 99-104 (1983)
18. Wong DT, Bymaster FP, Reid LR and Threlkeld PG: Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors. Biochem Pharmacol 32, 1287-1293 (1983)
19. Classen V, Davies JE, Hertting G and Placheta P: Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 60, 505-516 (1977)
20. Hyttel J and Lare JJ: Serotonin-selective antidepressants. Acta Pharmacol Toxicol 56, 146-153 (1985)
21. Raisman R, Briley MS and Langer SZ: Specific tricyclic anti-depressant binding sites in rat brain. Nature 281, 148-150 (1979)
22. Rehavi M, Paul SM, Skolnick P and Goodwin FK: Demonstration of specific high affinity binding sites for 3H-imipramine in human brain. Life Sci 26, 2273-2279 (1980)
23. 3H-imipramine binding site and the serotonin uptake mechanism. Br J Pharmacol 74, 817-818 (1981)
24. 3H-imipramine and the serotonin transporter in human platelets. J Neurochem 48, 560-565 (1987)
25. Briley MS, Langer SZ, Raisman R and Sechter D: Tritiated imipramine binding sites are decreased in platelets untreated depressed patients. Science 209, 303-305 (1980)
26. Paul SM, Rehavi M, Skolnik P, Balleger JC and Goodwin FK: Depressed patients have decreased binding of tritiated imipramine to platelet serotonin transporter. Arch Gen Psychiatry 38, 1315-1317 (1981)
27. Tuomisto J and Tukianien E: Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients. Nature 262, 596-598 (1976)
28. 3H-paroxetine binding to serotonin uptake sites in human brain tissue. Brain Res 486, 261-268 (1989)
29. 3H-imipramine localization and relationship to serotonin transporter. J Pharmacol Exp Ther 252, 410-418 (1990)
30. 3H-imipramine binding. Eur J Pharmacol 61, 373-380 (1980)
31. 3H-imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine. Science 210, 1113-1135 (1980)
32. 3H-imipramine binding sites and serotonin uptake system: indication of possible interdependence. Eur J Pharmacol 83, 151-152 (1982)
33. Barbaccia ML, Gandolfi O, Chuang DM and Costa E: Modulation of neuronal serotonin uptake by a putative endogenous ligand of imipramine recognition sites. Proc Natl Acad Sci USA 80, 5134-5138 (1983)
34. Racagni G, Mocchetti I, Calderini G, Battistella A and Brunello N: Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment: receptor desensitization and neurotransmitter interactions. Neuropharmacology 22, 415-424 (1983)
35. 3H-Imipramine high affinity binding sites in rat brain. Effects of imipramine and lithium. Psychopharmacology (Berlin) 77, 94-97 (1982)
36. Lee CM, Javitch JA and Snyder SH: Recognition sites for norepinephrine uptake. Regulation by neurotransmitter. Science 220, 626-629 (1983)
37. 3H-cyanoimipramine binding in rat brain tissue. Effect of long-term antidepressant administration. J Neural Transm 59, 257-264 (1984)
38. Humphreys CJ, Levin J and Rudnick G: Antidepressant binding to the porcine and human platelet serotonin transporters. Mol Pharmacol 33, 657-663 (1988)
39. 3H-imipramine binding and serotonin uptake in rat cerebral cortex after prolonged treatment. Fundam Clin Pharmacol 1, 327-333 (1987)
40. Laperre YD, Rastogi RB and Singhal RL: Fluvoxamine influences serotonergic system in the brain: neurochemical evidence. Neuropsychobiology 10, 213-216 (1983)
41. Invernizzi R, Belli S and Samanin R: Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex. Brain Res 584, 322-324 (1992)
42. Ogren SO, Fuxe K, Agnati LF, Gustafsson JA, Jonsson G and Holm AC: Reevaluation of the indoleamine hypothesis of depression: evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 46, 85-103 (1979)